Medical Health & Life Science Research News

Detailed examination of the efficacy testing market worth 501.6 million USD by 2022

Medical Market Research

[109 Pages Report] Efficacy Testing Market categories the Global market by Type (Antimicrobial Efficacy Testing, Disinfectant Efficacy Testing), Product and Service (Consumables, Services), Application (Pharmaceutical Manufacturing, Cosmetic & Personal Care Products) & Geography

- Advertising -

Browse 63 market data Tables and 32 Figures spread through 109 Pages and in-depth TOC on "Efficacy Testing Market"

www.marketsandmarkets.com/Market-R…479831.html 

Early buyers will receive 10% customization on this report

Factors driving the growth of this market include the increasing growth of pharmaceutical companies and rising outsourcing of efficacy testing by pharma, cosmetic, and medical devices companies. The high growth potential in emerging markets will provide growth opportunities for players operating in the Efficacy Testing Market.

The consumables segment is estimated to account for the largest market share in 2017 

By product and service, the market is classified into consumables, services, and instruments. The consumables segment is expected to lead the global Efficacy Testing Market in 2017.

- Advertising -

Factors driving the growth of this segment can be attributed to the regular and bulk purchases of consumables.

Inquiry Report @ www.marketsandmarkets.com/Enquiry_…m_campaign=paidpr

The pharmaceutical manufacturing segment is expected to dominate the market in 2017 

By pharmaceutical manufacturing, the market is segmented into pharmaceutical manufacturing, cosmetic and personal care products, and medical devices. The pharmaceutical manufacturing segment is expected to account for the largest share of the global Efficacy Testing Market in 2017.

Rising growth of pharmaceutical industries are a major factor responsible for the dominant share of this segment.

North America is estimated to command the largest share of the market 

Based on region, the Efficacy Testing Market is segmented into North America, Europe, Asia, and Rest of the World (RoW). North America is expected to dominate the Efficacy Testing Market in 2017.

This is attributed to factors such as by the availability of government funding for life science research activities, high R&D investments by pharmaceutical companies, and the presence of stringent drug development regulations as compared to other regions.

Download PDF Brochure@  www.marketsandmarkets.com/pdfdownl…m_campaign=paidpr

Key players in the Efficacy Testing Market include Eurofins Scientific (Luxembourg), Charles River Laboratories International (US), Becton, Dickinson and Company (US), SGS (Switzerland), Merck KGaA (Germany), bioMérieux (France), Pacific Biolabs (US), WuXi AppTec (China), North American Science Associates (US), and American Type Culture Collection (US) are the major players operating in the global Efficacy Testing Market.

News From

MarketsandMarkets™ - Business ResearchMarketsandMarkets™
Category: Market Research Publishers and RetailersCompany about: MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth ...
This email address is being protected from spambots. You need JavaScript enabled to view it.